Curium Company Profile
What is the competitive landscape for CURIUM
CURIUM has twenty-two approved drugs.
There are four US patents protecting CURIUM drugs.
Summary for Curium
| US Patents: | 4 |
| Tradenames: | 19 |
| Ingredients: | 19 |
| NDAs: | 22 |
| Patent Litigation for Curium: | See patent lawsuits for Curium |
Drugs and US Patents for Curium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Curium | IOFLUPANE I-123 | ioflupane i-123 | SOLUTION;INTRAVENOUS | 213792-001 | Mar 30, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Curium | BEXLUTRY | lutetium lu-177 dotatate | SOLUTION;INTRAVENOUS | 218525-001 | Sep 14, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Curium | PHOSPHOCOL P32 | chromic phosphate p-32 | INJECTABLE;INJECTION | 017084-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Curium | SODIUM CHROMATE CR 51 | sodium chromate cr-51 | INJECTABLE;INJECTION | 016708-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Curium | OCTREOSCAN | indium in-111 pentetreotide kit | INJECTABLE;INJECTION | 020314-001 | Jun 2, 1994 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Curium | ULTRA-TECHNEKOW V4 | technetium tc-99m sodium pertechnetate generator | SOLUTION;INTRAVENOUS | 017243-003 | Feb 18, 2014 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Curium | INDIUM IN 111 CHLORIDE | indium in-111 chloride | INJECTABLE;INJECTION | 019841-001 | Sep 27, 1994 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Curium
International Patents for Curium Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20230066382 | ⤷ Start Trial |
| Hungary | E052723 | ⤷ Start Trial |
| Poland | 2750717 | ⤷ Start Trial |
| Hungary | E044625 | ⤷ Start Trial |
| Spain | 2842998 | ⤷ Start Trial |
| Denmark | 2750717 | ⤷ Start Trial |
| Japan | 2023539893 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Curium Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3347352 | SPC/GB22/064 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: LENACAPAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR LENACAPAVIR SODIUM; REGISTERED: UK EU/1/22/1671(FOR NI) 20220819; UK MORE ON HISTORY TAB 20220819 |
| 1178838 | 300736 | Netherlands | ⤷ Start Trial | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
| 2380576 | 20C1048 | France | ⤷ Start Trial | PRODUCT NAME: SEL DE SODIUM DE L'ACIDE DESOXYCHOLIQUE; NAT. REGISTRATION NO/DATE: NL46299 20180810; FIRST REGISTRATION: IS - IS/1/16/071/01 20160729 |
| 2822954 | 2018/031 | Ireland | ⤷ Start Trial | PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM.; REGISTRATION NO/DATE: EU/1/18/1289 20180625 |
| 2666774 | CA 2020 00037 | Denmark | ⤷ Start Trial | PRODUCT NAME: RELEBACTAM, OPTIONALLY IN THE FORM OF THE MONOHYDRATE, IMIPENEM AND CILASTATIN, OPTIONALLY IN THE FORM OF THE SODIUM SALT; REG. NO/DATE: EU/1/19/1420 20200217 |
| 1948158 | 93075 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: SACUBITRIL ET VALSARTAN, SOUS FORME DE COMPLEXE SODIQUE SACUBITRIL VALSARTAN, C'EST-A-DIRE DE (3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3'-METHYL-2-(PENTANYOL(2''-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE) DE TRISODIUM HEMIPENTAHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/15/1058 20151123 |
| 2203431 | 2015/009 | Ireland | ⤷ Start Trial | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REGISTRATION NO/DATE: EU/1/14/983 20150115 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.

